Canadian Company Tilray Makes Deals with Novartis and Anheiser-Busch

It’s a clean sweep. Within the last two weeks, Big Tobacco, Big Pharma and Big Alcohol have all made moves into the Canadian cannabis industry:
• On Dec. 7, Marlboro cigarette maker Altria Group purchased 45% of Toronto-based Cronos Group (NASDAQ: CRON) for $1.8 billion.
• On Dec. 18, Swiss pharmaceutical giant Novartis (they own Sandoz) inked a deal with British Columbia-based Tilray Inc. to make medical cannabis products available through Novartis’ distribution network in 35 countries.
• On Dec. 20, Belgium-based Anheiser-Busch InBev partnered with Tilray to spend $100 million researching CBD and THC non-alcoholic drinks. Each company will pitch in $50 million. A-B InBev owns Budweiser, Stella Artois, Labatt’s and literally hundreds of other beer brands.

(function($){
function bsaProResize() {
var sid = “12”;
var object = $(“.bsaProContainer-” + sid + ” .bsaProItemInner__img”);
var animateThumb = $(“.bsaProContainer-” + sid + ” .bsaProAnimateThumb”);
var innerThumb = $(“.bsaProContainer-” + sid + ” .bsaProItemInner__thumb”);
var parentWidth = “772”;
var parentHeight = “105”;
var objectWidth = object.width();
if ( objectWidth < parentWidth ) { var scale = objectWidth / parentWidth; if ( objectWidth > 0 && objectWidth != 100 && scale > 0 ) {
animateThumb.height(parentHeight * scale);
innerThumb.height(parentHeight * scale);
object.height(parentHeight * scale);
} else {
animateThumb.height(parentHeight);
innerThumb.height(parentHeight);
object.height(parentHeight);
}
} else {
animateThumb.height(parentHeight);
innerThumb.height(parentHeight);
object.height(parentHeight);
}
}
$(document).ready(function(){
bsaProResize();
$(window).resize(function(){
bsaProResize();
});
});
})(jQuery);

(function ($) {
var bsaProContainer = $(‘.bsaProContainer-12’);
var number_show_ads = “0”;
var number_hide_ads = “0”;
if ( number_show_ads > 0 ) {
setTimeout(function () { bsaProContainer.fadeIn(); }, number_show_ads * 1000);
}
if ( number_hide_ads > 0 ) {
setTimeout(function () { bsaProContainer.fadeOut(); }, number_hide_ads * 1000);
}
})(jQuery);

TILRAY CEO BRENDAN KENNEDY: “It’s too early to know how big cannabinoid-based beverages will be, but we think it’s a massive opportunity and it’s something we’re interested in investing aggressively in.”

Previously, Canopy Growth and Hexo Group made deals with alcohol companies Constellation Brands and Molson Coors, respectively. Constellation – which owns Corona, Mondavi and other brands – invested $4 billion in Canopy.
About the A-B InBev deal, Tilray’s CEO Brendan Kennedy stated: “It’s too early to know how big cannabinoid-based beverages will be, but we think it’s a massive opportunity and it’s something we’re interested in investing aggressively in.”
After its big week, Tilray’s stock, NASDAQ: TLRY, was up 15% to $79.
Related Articles
The Meteoric Rise of Canada’s Legal Cannabis Industry
The Top 12 Canadian Pot Stocks
The View from Vancouver: Inside Canada’s Legalization Challenge
If you enjoyed this Freedom Leaf article, subscribe to the magazine here
The post Canadian Company Tilray Makes Deals with Novartis and Anheiser-Busch appeared first on Freedom Leaf.

Go to Source

Powered by WPeMatico